APA (7th ed.) Citation

S, S., Z, K., JS, C., & P, K. (2025). Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 39(1), 167. https://doi.org/10.1007/s40259-024-00693-y

Chicago Style (17th ed.) Citation

S, Szwec, Kapłucha Z, Chamberlain JS, and Konieczny P. "Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 39, no. 1 (2025): 167. https://doi.org/10.1007/s40259-024-00693-y.

MLA (9th ed.) Citation

S, Szwec, et al. "Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 39, no. 1, 2025, p. 167, https://doi.org/10.1007/s40259-024-00693-y.